Evidence map›Paper›PMID 32325482›Full record

ArticlePloS one2020

Aerococcus urinae - A potent biofilm builder in endocarditis.

Berrin Yaban, Judith Kikhney, Michele Musci, Annett Petrich, Julia Schmidt, Maria Hajduczenia, Felix Schoenrath, Volkmar Falk, Annette Moter

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Observational
  2. Article
  3. Emerging pathogensFuture microbiology · 2024
    Article
  4. IDCases · 2024
    Article
  5. Review
  6. Article
  7. Article
  8. Nanomedicine to fight infectious disease.Advanced drug delivery reviews · 2021
    Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Berrin YabanBiofilmzentrum, Dept. of Microbiology, Infectious Disease and Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Judith KikhneyBiofilmzentrum, Dept. of Microbiology, Infectious Disease and Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.ORCID 0000-0002-4849-7947
Michele MusciDept. of Congenital Heart Surgery-Pediatric Heart Surgery, German Heart Center Berlin, Berlin, Germany.
Annett PetrichBiofilmzentrum, Dept. of Microbiology, Infectious Disease and Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Julia SchmidtBiofilmzentrum, Dept. of Microbiology, Infectious Disease and Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Maria HajduczeniaBiofilmzentrum, Dept. of Microbiology, Infectious Disease and Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Felix SchoenrathDept. of Cardiothoracic and Vascular Surgery, German Heart Center Berlin, Berlin, Germany.
Volkmar FalkDept. of Cardiothoracic and Vascular Surgery, German Heart Center Berlin, Berlin, Germany.ORCID 0000-0002-7911-8620
Annette MoterBiofilmzentrum, Dept. of Microbiology, Infectious Disease and Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Humboldt-Universität zu Berlin · DEDeutsches Herzzentrum der Charité · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The diagnosis of infective endocarditis (IE) remains a challenge. One of the rare bacterial species recently associated with biofilms and negative cultures in infective endocarditis is Aerococcus urinae. Whether the low number of reported cases might be due to lack of awareness and misidentification, mainly as streptococci, is currently being discussed. To verify the relevance and biofilm potential of Aerococcus in endocarditis, we used fluorescence in situ hybridization to visualize the microorganisms within the heart valve tissue. We designed and optimized a specific FISH probe (AURI) for in situ visualization and identification of A. urinae in sections of heart valves from two IE patients whose 16S rRNA gene sequencing had deteced A. urinae. Both patients had a history of urinary tract infections. FISH visualized impressive in vivo grown biofilms in IE, thus confirming the potential of A. urinae as a biofilm pathogen. In both cases, FISH/PCR was the only method to unequivocally identify A. urinae as the only causative pathogen for IE. The specific FISH assay for A. urinae is now available for further application in research and diagnostics. A. urinae should be considered in endocarditis patients with a history of urinary tract infections. These findings support the biofilm potential of A. urinae as a virulence factor and are meant to raise the awareness of this pathogen.

Indexed as

BiofilmsAerococcusAgedAged, 80 and overEndocarditis, BacterialFemaleHeart ValvesHumansIn Situ Hybridization, FluorescenceMaleUrinary Tract Infections

Identifiers

PMID32325482
PMCPMC7180067
OpenAlexW3018316866

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.